PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMk3475
Mk3475
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2974 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD002289——270310128554642
NeoplasmsD009369—C8040825116419538
MelanomaD008545——19120228137373
Squamous cell carcinoma of head and neckD000077195——13017726211285
CarcinomaD002277—C80.010616927118272
Breast neoplasmsD001943EFO_0003869C5010415017112238
Triple negative breast neoplasmsD064726——931241516203
Renal cell carcinomaD002292EFO_0000376—89861519161
Stomach neoplasmsD013274EFO_0003897C1666751414127
AdenocarcinomaD000230——3778512110
Show 15 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lung neoplasmsD008175—C34.9012214939—33279
Colorectal neoplasmsD015179——115989—11189
Neoplasm metastasisD009362EFO_0009708—1088318—5169
Squamous cell carcinomaD002294——6110114—7155
Head and neck neoplasmsD006258——628616—5136
Ovarian neoplasmsD010051EFO_0003893C5669765—2121
Hepatocellular carcinomaD006528—C22.040549—18102
Liver neoplasmsD008113EFO_1001513C22.0405210—1599
Transitional cell carcinomaD002295——406112—794
Urologic neoplasmsD014571—C64-C6846567—489
Show 79 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228—C85.92323———35
B-cell lymphomaD016393——1718——131
Large b-cell lymphoma diffuseD016403—C83.31519———28
Castration-resistant prostatic neoplasmsD064129——1213———23
Colonic neoplasmsD003110—C181515———23
Pancreatic ductal carcinomaD021441——1415———22
Follicular lymphomaD008224—C821213———20
T-cell lymphomaD016399——915———18
Myeloid leukemia acuteD015470—C92.099———16
GliomaD005910EFO_0000520—89——315
Show 194 more
Indications Phases 1
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use